Counting the cost of type 2 diabetes in Vanuatu

Diabetes Research and Clinical Practice

Volumn 87, Issue 1, 2010, Pages 92-97

  Falconer, Douglas George ^a   Buckley, Alexandra ^a   Colagiuri, Ruth ^a  

^a University of Sydney   (Australia)

Author keywords

Cost; Type 2 diabetes; Vanuatu

Indexed keywords

INSULIN; NON PRESCRIPTION DRUG; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DIET THERAPY; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT TRANSPORT; PRESCRIPTION; QUALITY OF LIFE; VANUATU;

AUSTRALIA; CAREGIVERS; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG PRESCRIPTIONS; FAMILY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; PACIFIC ISLANDS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 73749086184     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.09.022     Document Type: Article

References (18)

1. Tukuitonga C. Meeting of Health Ministers for the Pacific Island Countries. Vanuatu (2007)
2. Abegunde D.O., Mathers C.D., Adam T., Ortegon M., and Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370 (2007) 1929-1938
3. Preventing Chronic Diseases: A Vital Investment, WHO 2005. www.who.int/chp/chronic_disease_report/contents/en/index.html.
4. International Diabetes Federation, Diabetes Atlas 2007, Brussels, 2007.
5. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. Diabetes Care 27 (2004) 1047-1053
6. Roglic G., Unwin N., Bennett P.H., Mathers C., Tuomilehto J., Nag S., et al. The burden of mortality attributable to diabetes. Diabetes Care 28 (2005) 2130-2135
7. Vanuatu Ministry of Health, Non-Communicable Diseases (NCD) STEPS Survey 2005.
8. Zing P., Enelgau M.M., Norris S.L., Gregg E.W., and Venkat Narayan K.M. Application of economic analysis to diabetes and diabetes care. Ann. Intern. Med. 140 (2004) 972-977
9. S. Colagiuri, R. Colagiuri, B. Conway, D. Grainger, P. Davey, DiabCo$t Australia: Assessing the burden of type 2 diabetes in Australia, Diabetes Australia, Canberra, 2003.
10. WHO's Western Pacific regional analysis of health care expenditure. The World Health Report 2002. World Health Organization, Geneva, 2003.
11. The Vanuatu NHA Team, Vanuatu National Health Accounts 2005. West Pacific Regional Office, 2007. Retrieved March 20, 2008, from www.who.int/nha/country/vut/Vanuatu%20NHA05%20draft.pdf.
12. C. Doran, Pacific action for health project: Economic impact of assessment of non-communicable diseases on hospital resources in Tonga, Vanuatu and Kiribati, Final report September 2003.
13. Colagiuri R. Building capacity to reduce diabetes complications in the pacific: The Vanuatu experience so far. Pract. Diabetes Int. 23 (2006)
14. EuroQol EQ-5D user guide, Version A (6/96), Publication Department, Centre for Health Economics, University of York, York.
15. Reserve Bank of Vanuatu financial and economic news summary, Issue 104 (August, 2006), Retrieved April 22, 2008, from www.rbv.gov.vu/Publications/Monthly/2006/AUG06.pdf.
16. Bhandari A., and Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med. Care Res. Rev. 63 No. 2 (2006) 217-235
17. Colagiuri S., Colagiuri R., Na'ati S., Muimuiheata S., Hussain Z., and Paul T. Prevalence of Diabetes in the Kingdom of Tonga. Diabetes Care 25 8 (2002) 1378-1383
18. Williams R., Van Gaal L., and Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45 (2002) S13-S17